These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 2831707

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Long-term effects of intestinal alpha-glucosidase inhibition on postprandial glucose, pancreatic and gut hormone responses and fasting serum lipids in diabetics on sulphonylureas.
    Uttenthal LO, Ukponmwan OO, Wood SM, Ghiglione M, Ghatei MA, Trayner IM, Bloom SR.
    Diabet Med; 1986 Mar; 3(2):155-60. PubMed ID: 2951158
    [Abstract] [Full Text] [Related]

  • 3. Combined use of guar and acarbose in reduction of postprandial glycaemia.
    Jenkins DJ, Taylor RH, Nineham R, Goff DV, Bloom SR, Sarson D, Alberti KG.
    Lancet; 1979 Nov 03; 2(8149):924-7. PubMed ID: 91023
    [Abstract] [Full Text] [Related]

  • 4. Acute and short term effects of intestinal alpha-glucosidase inhibition on gut hormone responses in man.
    Uttenthal LO, Ukponmwan OO, Ghiglione M, Bloom SR.
    Dig Dis Sci; 1987 Feb 03; 32(2):139-44. PubMed ID: 3542445
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enteroglucagon release in disaccharide malabsorption induced by intestinal alpha-glucosidase inhibition.
    Hayakawa T, Kondo T, Okumura N, Nagai K, Shibata T, Kitagawa M.
    Am J Gastroenterol; 1989 May 03; 84(5):523-6. PubMed ID: 2655436
    [Abstract] [Full Text] [Related]

  • 7. Long-term treatment in diabetics with acarbose, a glucosidase inhibitor: efficacy, tolerability and effect on GI hormones.
    Hillebrand I, Aubell R, Boehme K, Bloom SR, Berchtold P.
    Tohoku J Exp Med; 1983 Dec 03; 141 Suppl():683-6. PubMed ID: 6393444
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Scope and specificity of acarbose in slowing carbohydrate absorption in man.
    Jenkins DJ, Taylor RH, Goff DV, Fielden H, Misiewicz JJ, Sarson DL, Bloom SR, Alberti KG.
    Diabetes; 1981 Nov 03; 30(11):951-4. PubMed ID: 7028548
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method.
    Radziuk J, Kemmer F, Morishima T, Berchtold P, Vranic M.
    Diabetes; 1984 Mar 03; 33(3):207-13. PubMed ID: 6365657
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release.
    Enç FY, Imeryüz N, Akin L, Turoğlu T, Dede F, Haklar G, Tekeşin N, Bekiroğlu N, Yeğen BC, Rehfeld JF, Holst JJ, Ulusoy NB.
    Am J Physiol Gastrointest Liver Physiol; 2001 Sep 03; 281(3):G752-63. PubMed ID: 11518688
    [Abstract] [Full Text] [Related]

  • 16. Adaptation of the small intestine to induced maldigestion in rats. Experimental pancreatic atrophy and acarbose feeding.
    Creutzfeldt W, Fölsch UR, Elsenhans B, Ballmann M, Conlon JM.
    Scand J Gastroenterol Suppl; 1985 Sep 03; 112():45-53. PubMed ID: 3892654
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.